Chemical Compound

ACTODIGIN

CAS Registry Number 36983-69-4
ACTODIGIN chemical structure
Primary Record

ACTODIGIN

In stock
9,263 g
Purity
98.2 %
CAS
36983-69-4

Compound Identifiers & Properties

CAS
36983-69-4
PubChem CID
11954272
SMILES
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CCOC5=O)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O
Canonical SMILES
C[C@]12CC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CCOC3=O)CC[C@]12O

Names & Synonyms

  • ACTODIGIN
  • Actodigine
  • Actodiginum
  • Actodigina
  • Actodigino
  • Actodigin [USAN:INN]
  • Actodigine [INN-French]
  • Actodiginum [INN-Latin]
  • Actodigino [INN-Spanish]
  • ACTODIGIN [INN]
  • Actodigin (USAN/INN)
  • ACTODIGIN [USAN]
  • RefChem:915113
  • 9E4KL95FK9
  • UNII-9E4KL95FK9
  • 36983-69-4
  • AY 22241
  • SCHEMBL122586
  • NSC 53396
  • NSC-53396
  • DTXSID401043283
  • AY-22241
  • CHEMBL2103957
  • AY-22,241
  • CHEBI:177433
  • DTXCID701525993
  • ZINC8214477
  • AY 22,241
  • 3-O-(beta-D-Glucopyranosyl)digitoxigenin
  • C29-H44-O9
  • CID11954272
  • 3-Amino-4-(2-methylpropylamino)quinoline
  • J19.343G
  • D02763
  • Q27272431
  • 4-[(3S,5R,8R,9S,10S,13R,14S,17S)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
  • 24-Nor-5,14-chol-20(22)-en-21-oic acid, 3-(beta-D-glucopyranosyloxy)-14,23-dihydroxy-, gamma-lactone, (3beta,5beta,14beta)-
  • 3 beta-D-glucopyranosyl-14 beta,24-dihydroxy-21,23-bisnor-5 beta-chol-20(22)-ene-20-carboxylic acid gamma-lactone
  • 3beta-(beta-D-Glucopyranosyloxy)-14,23-dihydroxy-24-nor-5beta,14beta-chol-20(22)-en-21-oic acid gamma-lactone
  • 24-Nor-5,14-chol-20(22)-en-21-oic acid, 3-(.|A.-D-glucopyranosyloxy)-14,23-dihydroxy-, .|A.-lactone, (3.|A.,5.|A.,14.|A.)-
  • 24-Nor-5,14-chol-20(22)-en-21-oic acid, 3-(.beta.-D-glucopyranosyloxy)-14,23-dihydroxy-, .gamma.-lactone, (3.beta.,5.beta.,14.beta.)-
  • 24-Norchol-20(22)-en-21-oic acid, 3-(.beta.-D-glucopyranosyloxy)-14,23-dihydroxy-, .gamma.-lactone, (3.beta.,5.beta.,14.beta.)-
  • 3-[(1S,3aS,3bR,5aR,7S,9aS,9bS,11aR)-3a-hydroxy-9a,11a-dimethyl-7-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one
  • 3.beta.-(.beta.-D-Glucopyranosyloxy)-14,23-dihydroxy-24-nor-5.beta.,14.beta.-chol-20(22)-en-21-oic acid .gamma.-lactone
  • 3beta-(beta-D-Glucopyranosyloxy)-14beta,23-dihydroxy-24-nor-5beta-chol-20(22)-en-21-oic acid gamma-lactone
  • 4-[(3S,5R,8R,9S,10S,13R,14S,17S)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-uran-5-one